Breaking News Instant updates and real-time market news.

FLKS

Flex Pharma

$8.43

-2.77 (-24.73%)

08:49
10/14/16
10/14
08:49
10/14/16
08:49

Flex Pharma downgraded to Hold from Buy at Cantor

Cantor Fitzgerald analyst Mara Goldstein downgraded Flex Pharma to Hold and lowered her price target for the shares to $10 from $22. The analyst calls yesterday's Phase II results of FLKS-787 "messy."

  • 29

    Nov

FLKS Flex Pharma
$8.43

-2.77 (-24.73%)

12/17/15
PIPR
12/17/15
NO CHANGE
PIPR
Alexion buyout among Piper's potential Biopharma surprises in 2016
Piper Jaffray's Biopharma team, led by analyst Joshua Schimmer, announced their top potential surprise events for the sector in 2016. Schimmer's potential outcomes in 2016 include Gilead (GILD) buying Alexion (ALXN), Akorn (AKRX) being delisted by the Nasdaq, Shire (SHPG) reaching a deal to acquire Baxalta (BXLT), the Allergan (AGN), Pfizer (PFE) merger closing, NBA superstar LeBron James starting to drink Flex Pharma's (FLKS) "It's The Nerve" sports beverage, and Valeant (VRX) splitting itself up. Schimmer admits some of the predictions are low-probability events. Other potential outcomes making the list include four Duchenne muscular dystrophy drugs gaining FDA approval, followed by TheStreet's Adam Feuerstein offering a retraction, concerns over drug pricing abating, and Sangamo's (SGM) HIV program proven to be a "black swan."
04/11/16
ROTH
04/11/16
NO CHANGE
Target $24
ROTH
Buy
Roth Capital remains positive on Flex Pharma after 'encouraging' data
Roth Capital analyst Joseph Pantginis remains positive on Flex Pharma, following data from a second model of muscle cramping. The data showed statistically significant reductions in muscle cramping as well as positive impacts on muscle soreness, Pantginis tells investors in a research note, adding that he is now looking to visibility out of the soft launch of the consumer product this quarter. The analyst's projections for success remain unchanged, but he is taking a more conservative approach to his revenue projections as the "cult" brand is built. Pantginis reiterates a Buy rating and lowered his price target on the shares to $24 from $27.
10/13/16
PIPR
10/13/16
NO CHANGE
Target $25
PIPR
Overweight
Flex Pharma explanations for trial setbacks 'quite sound,' says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer noted that Flex Pharma has run into to some setbacks with its nocturnal leg cramping program, but he said the explanations provided by the company for the issues are "quite sound" in his opinion. Schimmer believes the totality of the data support FLKS-787 as a potential therapeutic for nocturnal leg cramps and possibly other disorders, he tells investors. The analyst keeps an Overweight rating and $25 price target on Flex Pharma shares, which are down 22% to $8.70 in afternoon trading.

TODAY'S FREE FLY STORIES

SQM

SQM

$58.59

-4.14 (-6.60%)

08:12
01/17/18
01/17
08:12
01/17/18
08:12
Upgrade
SQM rating change  »

SQM upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$18.51

-0.19 (-1.02%)

08:12
01/17/18
01/17
08:12
01/17/18
08:12
Periodicals
Deutsche Bank to shift fewer London jobs than expected, Reuters reports »

Deutsche Bank expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

F

Ford

$13.10

-0.13 (-0.98%)

08:11
01/17/18
01/17
08:11
01/17/18
08:11
Technical Analysis
Technical Take: Ford down following update, FY17 and FY18 EPS view »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

VBIV

VBI Vaccines

$4.36

-0.1 (-2.24%)

08:10
01/17/18
01/17
08:10
01/17/18
08:10
Hot Stocks
VBI Vaccines doses first patient in Phase 1/2a clinical study of VBI-1901 »

VBI Vaccines announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DERM

Dermira

$26.96

-0.48 (-1.75%)

08:09
01/17/18
01/17
08:09
01/17/18
08:09
Recommendations
Dermira analyst commentary  »

Dermira price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jun

LFUS

Littelfuse

$205.55

-0.9 (-0.44%)

, IXYS

IXYS

$23.05

-1.55 (-6.30%)

08:09
01/17/18
01/17
08:09
01/17/18
08:09
Hot Stocks
Littelfuse completes acquisition of IXYS »

Littelfuse (LFUS)…

LFUS

Littelfuse

$205.55

-0.9 (-0.44%)

IXYS

IXYS

$23.05

-1.55 (-6.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

DKS

Dick's Sporting

$32.33

-1 (-3.00%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Technical Analysis
Technical Take: Dick's Sporting higher in pre-market, analyst action »

At time of writing, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Conference/Events
Board of Governors of the Federal Reserve System holds a closed meeting »

The Board of Governors of…

MGP

MGM Growth

$29.50

0.96 (3.36%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Hot Stocks
VICI Properties rejects unsolicited proposal from MGM Growth »

VICI Properties confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEUM

Pareteum

$2.31

-0.07 (-2.94%)

08:08
01/17/18
01/17
08:08
01/17/18
08:08
Hot Stocks
Pareteum awarded $3M contract to add mobility to South American data provider »

Pareteum has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSOD

Cornerstone OnDemand

$38.94

-0.23 (-0.59%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
Cornerstone OnDemand to separate chairman and CEO roles »

Cornerstone OnDemand…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 13

    Mar

ATVI

Activision Blizzard

$68.71

-1.65 (-2.35%)

, AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
Overwatch League opening week draws more than 10M viewers »

The Overwatch League…

ATVI

Activision Blizzard

$68.71

-1.65 (-2.35%)

AMZN

Amazon.com

$1,304.86

-0.34 (-0.03%)

NTES

NetEase

$322.08

-6.75 (-2.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 17

    Jan

  • 18

    Jan

  • 18

    Jan

  • 07

    Feb

  • 08

    Feb

  • 18

    Mar

KNX

Knight-Swift

$44.63

-0.37 (-0.82%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Conference/Events
Knight-Swift management to meet with Deutsche Bank »

Field trip to company…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

  • 30

    Jan

MPLX

MPLX

$38.28

-0.5 (-1.29%)

08:07
01/17/18
01/17
08:07
01/17/18
08:07
Hot Stocks
MPLX announces joint open season for Cushing-to-Patoka pipeline expansion »

MPLX announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UNH

UnitedHealth

$232.90

4.26 (1.86%)

08:06
01/17/18
01/17
08:06
01/17/18
08:06
Recommendations
UnitedHealth analyst commentary  »

UnitedHealth price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DE

Deere

$167.54

-1.76 (-1.04%)

08:06
01/17/18
01/17
08:06
01/17/18
08:06
Recommendations
Deere analyst commentary  »

Deere price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

RIOT

Riot Blockchain

$18.28

-3.6 (-16.45%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Hot Stocks
Riot Blockchain's Tess Pay signs agreement for Cresval Capital transaction »

Riot Blockchain's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

WAFD

Washington Federal

$35.60

-0.05 (-0.14%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Earnings
Washington Federal reports Q4 EPS 59c, consensus 51c »

Return on equity for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

08:05
01/17/18
01/17
08:05
01/17/18
08:05
Earnings
Ichor Holdings sees Q1 revenue $240M-$250M, consensus $208.35M »

For 1Q18, Ichor expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

OBE

Obsidian Energy

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Hot Stocks
FrontFour Capital voices concerns regarding Obsidian Energy »

FrontFour Capital Group,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSBC

HSBC

$54.90

0.07 (0.13%)

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Downgrade
HSBC rating change  »

HSBC downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICHR

Ichor Holdings

$25.60

0.86 (3.48%)

08:04
01/17/18
01/17
08:04
01/17/18
08:04
Earnings
Ichor Holdings sees Q4 revenue $183M, consensus $181.17M »

Ichor Holdings announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

RGC

Regal Entertainment

$22.90

-0.07 (-0.30%)

08:03
01/17/18
01/17
08:03
01/17/18
08:03
Downgrade
Regal Entertainment rating change  »

Regal Entertainment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GE

General Electric

$18.21

-0.55 (-2.93%)

08:03
01/17/18
01/17
08:03
01/17/18
08:03
Hot Stocks
GE Transportation signs locomotive, service agreements valued at over $900M »

GE Transportation signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

DWDP

DowDuPont

$74.95

-0.46 (-0.61%)

08:02
01/17/18
01/17
08:02
01/17/18
08:02
Hot Stocks
DowDuPont, UC Davis team up to advance orphan African crops »

Dow AgroSciences teamed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.